QI
LJPC

QS Investors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

QS Investors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-700
Closed -$3K – 1679
2020
Q2 		$3K Hold
700
– – ﹤0.01% 1631
2020
Q1 		$3K Hold
700
– – ﹤0.01% 1638
2019
Q4 		$3K Buy
+700
New +$4.13K ﹤0.01% 1614

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

QS Investors's LJPC Position: Q3 2020 in Review

QS Investors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 700 shares — an estimated $3K sold.

QS Investors first reported a position in LJPC in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • QS Investors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 700 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $3K.
  • QS Investors first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 3 quarters.
  • QS Investors's La Jolla Pharmaceutical Company position peaked at $3K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.